Top Industry News
- FSANZ-Approval Report – Application A1283 2′-FL from GM Corynebacterium Glutamicum in Infant Formula Products
- NPRA - Registration Application Submitted via Facilitated Registration Pathway (FRP) - FAQs
- WHO- Safety Evaluation of Certain Food Additives
- ANVISA Announces Startup Projects Selected to Receive Regulatory Guidance on Drug Innovation
- Health Canada's Marketing Authorization allows for the voluntary addition of vitamin D to yogurt and kefir to address low Vitamin D levels in Canadians and support bone health
- MCNZ Consultation - Expedited pathway for registration in the Provisional Vocational scope of practice
- FDA Guidance on Laboratory Developed Tests: Small Entity Compliance
- The first report of the HoA working group 'Food Supplements' highlights the need for harmonization and regulation of 'other substances' in food supplements
- EMA Recommends Non-Renewal of Authorisation of Duchenne Muscular Dystrophy Medicine Translarna
- GCC - New Cosmetic Technical Regulations Available
- FDA Draft Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies
- The European Commission (EC) recalled Loreal hair conditioner because the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products
- FDA Draft Guidance on Essential Drug Delivery Outputs for Devices Intended to Deliver Drugs and Biological Products
- AICIS-Chemicals included in the Inventory five years post issuance of assessment certificate
- ECHA adds one hazardous chemical to the Candidate List
- ANVISA Quarterly Update of Medical Device Economic Monitoring Dashboards Available
- CTPA Relaunches its Member-only “Cosmetics Masterclass”
- EMA Recommends Revoking Conditional Marketing Authorisation for Ocaliva
- ANVISA Publishes Studies on Agile Regulation and Experimental Regulation